ESS vs IRD · P/E 31, rev $1.89B vs rev $11.0M
Essex Property Trust Inc (ESS) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ESS and IRD stock pages for the full models.
Not investment advice.